Drug Profile
Z 207
Alternative Names: Z-207Latest Information Update: 09 Sep 2015
Price :
$50
*
At a glance
- Originator Unknown
- Developer Zeria
- Class Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Seasonal allergic rhinitis